These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3821785)
1. Recent advances in the pathogenesis of diabetic neuropathy. Low PA Muscle Nerve; 1987 Feb; 10(2):121-8. PubMed ID: 3821785 [TBL] [Abstract][Full Text] [Related]
2. Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Low PA; Schmelzer JD; Ward KK; Yao JK Am J Physiol; 1986 Jan; 250(1 Pt 1):E94-9. PubMed ID: 2934991 [TBL] [Abstract][Full Text] [Related]
3. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Low PA; Tuck RR; Dyck PJ; Schmelzer JD; Yao JK Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6894-8. PubMed ID: 6593734 [TBL] [Abstract][Full Text] [Related]
4. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Østergaard L; Finnerup NB; Terkelsen AJ; Olesen RA; Drasbek KR; Knudsen L; Jespersen SN; Frystyk J; Charles M; Thomsen RW; Christiansen JS; Beck-Nielsen H; Jensen TS; Andersen H Diabetologia; 2015 Apr; 58(4):666-77. PubMed ID: 25512003 [TBL] [Abstract][Full Text] [Related]
5. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Zochodne DW; Ho LT Can J Neurol Sci; 1992 Nov; 19(4):433-41. PubMed ID: 1423041 [TBL] [Abstract][Full Text] [Related]
6. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Malik RA; Tesfaye S; Thompson SD; Veves A; Sharma AK; Boulton AJ; Ward JD Diabetologia; 1993 May; 36(5):454-9. PubMed ID: 8314451 [TBL] [Abstract][Full Text] [Related]
7. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. Sima AA; Lattimer SA; Yagihashi S; Greene DA J Clin Invest; 1986 Feb; 77(2):474-84. PubMed ID: 3003160 [TBL] [Abstract][Full Text] [Related]
13. Nerve lipid abnormalities in human diabetic neuropathy: a correlative study. Brown MJ; Iwamori M; Kishimoto Y; Rapoport B; Moser HW; Asbury AK Ann Neurol; 1979 Mar; 5(3):245-52. PubMed ID: 443757 [TBL] [Abstract][Full Text] [Related]
14. Is resistance to ischaemic conduction failure induced by hypoxia? Masson EA; Church SE; Woodcock AA; Hanley SP; Boulton AJ Diabetologia; 1988 Oct; 31(10):762-5. PubMed ID: 3240838 [TBL] [Abstract][Full Text] [Related]
16. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Malik RA; Newrick PG; Sharma AK; Jennings A; Ah-See AK; Mayhew TM; Jakubowski J; Boulton AJ; Ward JD Diabetologia; 1989 Feb; 32(2):92-102. PubMed ID: 2721843 [TBL] [Abstract][Full Text] [Related]
17. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H; Tawata M; Aida K; Onaya T J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [TBL] [Abstract][Full Text] [Related]
18. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225 [TBL] [Abstract][Full Text] [Related]
20. Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Low PA; Ward K; Schmelzer JD; Brimijoin S Am J Physiol; 1985 Apr; 248(4 Pt 1):E457-62. PubMed ID: 3985144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]